Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis
Junnan Wu, Ziyuan Ma, Archana Raman, et al.
Immunity (2021) Vol. 54, Iss. 11, pp. 2632-2649.e6
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Molecular pathways that drive diabetic kidney disease
Samer Mohandes, Tomohito Doke, Hailong Hu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 179
The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development
Tomohito Doke, Katalin Suszták
Trends in Cell Biology (2022) Vol. 32, Iss. 10, pp. 841-853
Open Access | Times Cited: 87
STING contributes to lipopolysaccharide-induced tubular cell inflammation and pyroptosis by activating endoplasmic reticulum stress in acute kidney injury
Cao Yun, Xinghua Chen, Zijing Zhu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 25
The key role of altered tubule cell lipid metabolism in kidney disease development
Lauren E. Lee, Tomohito Doke, Dhanunjay Mukhi, et al.
Kidney International (2024) Vol. 106, Iss. 1, pp. 24-34
Open Access | Times Cited: 22
The Pathogenesis of African Trypanosomiasis
Etienne Pays, Magdalena Radwanska, Stefan Magez
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 19-45
Open Access | Times Cited: 49
Mitochondrial VDAC1: A Potential Therapeutic Target of Inflammation-Related Diseases and Clinical Opportunities
Hang Hu, Linlin Guo, Jay Overholser, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3174-3174
Open Access | Times Cited: 46
APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program
Adriana M. Hung, Shailja C. Shah, Alexander G. Bick, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 4, pp. 386-386
Open Access | Times Cited: 43
Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease
Adriana M. Hung, Victoria A. Assimon, Hua‐Chang Chen, et al.
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 11, pp. 1889-1899
Open Access | Times Cited: 30
SIRT1-Rab7 axis attenuates NLRP3 and STING activation through late endosomal-dependent mitophagy during sepsis-induced acute lung injury
Tao Jiang, Enran Liu, Zhiyuan Li, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 13
Apolipoprotein L1 (APOL1) renal risk variant-mediated podocyte cytotoxicity depends on African haplotype and surface expression
Nidhi Gupta, Bridget Waas, Daniel Austin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Collapsing Focal Segmental Glomerulosclerosis in Viral Infections
Anne K. Muehlig, Sydney E. Gies, Tobias B. Huber, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 31
Necroptosis, Pyroptosis, Ferroptosis in Sepsis and Treatment
Mengdi Qu, Yanghanzhao Wang, Zhiyun Qiu, et al.
Shock (2022) Vol. 57, Iss. 6, pp. 161-171
Closed Access | Times Cited: 29
MLKL deficiency attenuated hepatocyte oxidative DNA damage by activating mitophagy to suppress macrophage cGAS-STING signaling during liver ischemia and reperfusion injury
Jian Xu, Dongming Wu, Shun Zhou, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Unified Mouse and Human Kidney Single-Cell Expression Atlas Reveal Commonalities and Differences in Disease States
Jianfu Zhou, Amin Abedini, Michael S. Balzer, et al.
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 11, pp. 1843-1862
Closed Access | Times Cited: 18
ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules
Dhanunjay Mukhi, Lingzhi Li, Hongbo Liu, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 4
Open Access | Times Cited: 18
The Immune System and Idiopathic Nephrotic Syndrome
Ruth E. Campbell, Joshua M. Thurman
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 12, pp. 1823-1834
Open Access | Times Cited: 26
APOL1 Nephropathy Risk Variants Through the Life Course: A Review
Ai Itoku, Jaya S. Isaac, Scott Wilson, et al.
American Journal of Kidney Diseases (2024) Vol. 84, Iss. 1, pp. 102-110
Open Access | Times Cited: 5
Modeling lung endothelial dysfunction in sepsis‐associated ARDS using a microphysiological system
Nai‐Wen Liang, Carole L. Wilson, Brooke A. Davis, et al.
Physiological Reports (2024) Vol. 12, Iss. 13
Open Access | Times Cited: 5
Emerging Viral Infections and the Potential Impact on Hypertension, Cardiovascular Disease, and Kidney Disease
Solomiia Savedchuk, Rasha Raslan, Sarah Nystrom, et al.
Circulation Research (2022) Vol. 130, Iss. 10, pp. 1618-1641
Open Access | Times Cited: 21
Expression Level Analysis of ACE2 Receptor Gene in African-American and Non-African-American COVID-19 Patients
Marion N. Nyamari, Kauthar M. Omar, Ayorinde F. Fayehun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 11
The actin and microtubule network regulator WHAMM is identified as a key kidney disease risk gene
Dhanunjay Mukhi, Lakshmi P. Kolligundla, Tomohito Doke, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115462-115462
Closed Access
SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2
Xiang Cai, Huanyi Cao, Meijun Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Increased Prevalence of Coronary Heart Disease Among Current Smokers Carrying APOL1 Risk Variants Within the African American Population
Jelena Mustra Rakic, Clive R. Pullinger, Erin L. Van Blarigan, et al.
Journal of clinical lipidology (2025)
Closed Access
SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2
Xiang Cai, Huanyi Cao, Meijun Wang, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Glutathione-specific gamma–glutamylcyclotransferase 1 ( CHAC1 ) increases kidney disease risk by modulating ferroptosis
Lakshmi P. Kolligundla, Katie Sullivan, Dhanunjay Mukhi, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 795
Closed Access
Page 1 - Next Page

Scroll to top